Search company, investor...

Predict your next investment

Corporation
fosunpharma.com

Investments

52

Portfolio Exits

13

Partners & Customers

10

About Fosun Pharmaceutical

Fosun Pharmaceutical (SHA: 600196) strategically covers a number of important aspects of the pharmaceutical health industry chain, from research and development, pharmaceutical manufacturing, medical diagnosis, and medical equipment to pharmaceutical distribution and retail and medical services, to contribute to public health.

Headquarters Location

Fosun Commercial Building No.2 Fuxing Road (East)

Shanghai, Shanghai, 200010,

China

+86-21-23138000

Want to inform investors similar to Fosun Pharmaceutical about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Research containing Fosun Pharmaceutical

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Fosun Pharmaceutical in 1 CB Insights research brief, most recently on Nov 12, 2020.

Latest Fosun Pharmaceutical News

Fosun's app allows users in China to register for BioNTech COVID vaccines In Hong Kong

Dec 27, 2022

(marketscreener.com) China's Fosun Pharmaceutical said users of its health mobile app in China can now register to have COVID-19 vaccinations in Hong Kong using BioNTech's vaccine.https://www.marketscreener.com/quote/stock/BIONTECH-SE-66771992/news/Fosun-s-app-allows-users-in-China-to-register-for-BioNTech-COVID-vaccines-In-Hong-Kong-42621040/?utm_medium=RSS&utm_content=20221227

Fosun Pharmaceutical Investments

52 Investments

Fosun Pharmaceutical has made 52 investments. Their latest investment was in Primelink Biotherapeutics as part of their Seed VC on November 11, 2022.

CBI Logo

Fosun Pharmaceutical Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/24/2022

Seed VC

Primelink Biotherapeutics

$14M

Yes

5

8/3/2022

Series B

SysDiagno Biotech

No

1

8/2/2022

Seed

Fosun AItrox

$14.8M

No

3

7/11/2022

Seed - II

Subscribe to see more

Subscribe to see more

10

5/5/2022

Series C

Subscribe to see more

Subscribe to see more

10

Date

11/24/2022

8/3/2022

8/2/2022

7/11/2022

5/5/2022

Round

Seed VC

Series B

Seed

Seed - II

Series C

Company

Primelink Biotherapeutics

SysDiagno Biotech

Fosun AItrox

Subscribe to see more

Subscribe to see more

Amount

$14M

$14.8M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

1

3

10

10

Fosun Pharmaceutical Portfolio Exits

13 Portfolio Exits

Fosun Pharmaceutical has 13 portfolio exits. Their latest portfolio exit was Hinova Pharmaceuticals on April 12, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/12/2022

IPO

$99M

Public

1

12/22/2021

Acquired

$99M

19

8/23/2021

Corporate Majority

$99M

1

8/20/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/18/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/12/2022

12/22/2021

8/23/2021

8/20/2021

6/18/2021

Exit

IPO

Acquired

Corporate Majority

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

19

1

10

10

Fosun Pharmaceutical Acquisitions

16 Acquisitions

Fosun Pharmaceutical acquired 16 companies. Their latest acquisition was OncoCare Cancer Centre on June 07, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/7/2022

$99M

Corporate Majority

4

10/28/2021

$99M

Corporate Majority

3

8/20/2021

Series A

$99M

Corporate Majority

1

9/17/2020

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2020

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/7/2022

10/28/2021

8/20/2021

9/17/2020

9/8/2020

Investment Stage

Series A

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Corporate Majority

Corporate Majority

Corporate Majority

Subscribe to see more

Subscribe to see more

Sources

4

3

1

10

10

Fosun Pharmaceutical Partners & Customers

10 Partners and customers

Fosun Pharmaceutical has 10 strategic partners and customers. Fosun Pharmaceutical recently partnered with BioNTech on December 12, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

12/22/2022

Licensor

Germany

BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China

BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators , including Genmab , Sanofi , Genentech , a member of the Roche Group , Regeneron , Genevant , Fosun Pharma , and Pfizer .

2

9/26/2022

Licensee

United States

Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product

Rong Yang , Chief Executive Officer of Fosun Pharma and Senior Vice President of Fosun Pharma said , `` We are excited that this product in partnership with MAIA Pharmaceuticals , Inc. has been recently launched which marks a milestone for Fosun Pharma 's business development in the US market . ''

3

9/7/2022

Licensor

Switzerland

Neovii and Fosun Pharma Enter Into an Exclusive Agreement

Under the Agreement Neovii Pharmaceuticals AG is entitled to receive upfront , regulatory and commercial sales milestones as well as proceeds from supplying Grafalon ® to Fosun Pharma .

2

7/26/2022

Licensor

China

Subscribe to see more

Subscribe to see more

10

2/17/2022

Partner

Hong Kong

Subscribe to see more

Subscribe to see more

10

Date

12/22/2022

9/26/2022

9/7/2022

7/26/2022

2/17/2022

Type

Licensor

Licensee

Licensor

Licensor

Partner

Business Partner

Country

Germany

United States

Switzerland

China

Hong Kong

News Snippet

BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China

BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators , including Genmab , Sanofi , Genentech , a member of the Roche Group , Regeneron , Genevant , Fosun Pharma , and Pfizer .

Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product

Rong Yang , Chief Executive Officer of Fosun Pharma and Senior Vice President of Fosun Pharma said , `` We are excited that this product in partnership with MAIA Pharmaceuticals , Inc. has been recently launched which marks a milestone for Fosun Pharma 's business development in the US market . ''

Neovii and Fosun Pharma Enter Into an Exclusive Agreement

Under the Agreement Neovii Pharmaceuticals AG is entitled to receive upfront , regulatory and commercial sales milestones as well as proceeds from supplying Grafalon ® to Fosun Pharma .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

3

2

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.